BusinessUSPTO Grants Composition of Matter Patent to Achillion for ACH-4471, First-in-Class Small Molecule Complement Alternative Pathway Factor D InhibitorBy Nasdaq OMXOct 24, 2017, 10:05 AM UTC
BusinessAchillion Presents Novel Research on Factor D Inhibition at the XXVIth International Complement WorkshopBy Nasdaq OMXSep 6, 2016, 10:05 AM UTC
